Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Mallinckrodt
Teva
Federal Trade Commission
Fuji
McKesson
Cipla
Queensland Health
Medtronic

Generated: December 10, 2018

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ISOSORBIDE DINITRATE

« Back to Dashboard

Clinical Trials for Isosorbide Dinitrate

Trial ID Title Status Sponsor Phase Summary
NCT00000478 Asymptomatic Cardiac Ischemia Pilot (ACIP) Study Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 To assess the feasibility of and test the methodology for a full-scale clinical trial of therapies for asymptomatic cardiac ischemia.
NCT00337116 Intravenous Isosorbide Dinitrate Versus Sublingual Isosorbide Dinitrate for the Relief of Acute Anginal Episodes in Acute Coronary Syndrome (ACS) Patients Withdrawn Soroka University Medical Center Phase 4 This is a randomized, double blind, placebo-controlled study, clinical trail designed to evaluate the efficacy safety and superiority of intravenous boluses of isosorbide dinitrate for the relief of acute anginal pain episodes in acute coronary syndrome patients in comparison with the usual manner of S/L isosorbide dinitrate .
NCT00685945 Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 Completed National Center for Research Resources (NCRR) N/A The purpose of the study is to determine if giving isosorbide,a drug that is used to treat chest pain, affects blood vessel release of an anti-clotting factor.
NCT00685945 Renin-Angiotensin Aldosterone System and Fibrinolysis Interaction in Humans-Specific Aim 3 Completed National Heart, Lung, and Blood Institute (NHLBI) N/A The purpose of the study is to determine if giving isosorbide,a drug that is used to treat chest pain, affects blood vessel release of an anti-clotting factor.
Trial ID Title Status Sponsor Phase Summary

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Isosorbide Dinitrate

Condition Name

Condition Name for Isosorbide Dinitrate
Intervention Trials
Heart Failure 5
Cardio-Renal Syndrome 2
Neuropathic Pain 1
Coronary Heart Disease 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Isosorbide Dinitrate
Intervention Trials
Heart Failure 7
Coronary Disease 3
Coronary Artery Disease 3
Myocardial Ischemia 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Isosorbide Dinitrate

Trials by Country

Trials by Country for Isosorbide Dinitrate
Location Trials
United States 31
China 3
Netherlands 1
Taiwan 1
Singapore 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Isosorbide Dinitrate
Location Trials
Alabama 3
Massachusetts 2
Pennsylvania 2
Ohio 2
New York 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Isosorbide Dinitrate

Clinical Trial Phase

Clinical Trial Phase for Isosorbide Dinitrate
Clinical Trial Phase Trials
Phase 4 6
Phase 3 5
Phase 2 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Isosorbide Dinitrate
Clinical Trial Phase Trials
Completed 10
Recruiting 4
Active, not recruiting 4
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Isosorbide Dinitrate

Sponsor Name

Sponsor Name for Isosorbide Dinitrate
Sponsor Trials
National Heart, Lung, and Blood Institute (NHLBI) 2
University of Pennsylvania 1
Haining Health-Coming Biotech Co., Ltd. 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Isosorbide Dinitrate
Sponsor Trials
Other 32
NIH 5
Industry 4
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Cerilliant
Baxter
Boehringer Ingelheim
Cipla
Merck
Dow
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.